Prescribing, Policies and Pathways
or
Medicine / Guideline | Indication | RAG rating | Document type | Place |
---|---|---|---|---|
Abrocitinib | Atopic dermatitis - moderate severe | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
Acitretin | Psoriasis, ichthyosis, Darier's disease | Red | Decision document | Hertfordshire and West Essex ICB |
Actinic keratosis | Actinic keratosis | n/a | Prescribing pathway | Hertfordshire and West Essex ICB |
Adalimumab | Psoriasis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Alitretinoin | Eczema - hand severe | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
Apremilast | Psoriasis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Aveeno switch patient letter | Emollient | Double Red | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
Back Pain | n/a | Clinical pathways | East and North Hertfordshire | |
Baricitinib | Alopecia areata | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
Baricitinib | Atopic dermatitis - moderate severe | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
Bath and shower preparations | Dry and pruritic skin conditions | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
Bimekizumab | Psoriasis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Biologic and Biosimilar Medicines | Where indicated | n/a | Patient information | Hertfordshire and West Essex ICB |
Botulinum toxin type A | Focal spasticity, Hemi-facial spasm, Blepharospasm, Cervical dystonia, Frey’s syndrome, Chronic anal fissure, Dysphagia, Hirschsprung’s disease, Overactive bladder,Masseteric hypertrophy and temporomandibular disorders | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
Brodalumab | Psoriasis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Certoliziumab | Psoriasis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Chalazia (meibomian cysts) removal | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
Chalazia Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
Chlormethine gel | Mycosis fungoides-type cutaneous T-cell lymphoma (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
Dermatology / Skin Lesions / Skin Health for Adults over 16 years old | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
Deucravacitinib | Psoriasis - moderate severe | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
Diclofenac sodium 3% gel | Actinic keratosis | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
Dimethyl fumarate | Psoriasis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Dupilumab | Prurigo Nodularis | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
Dupilumab | Atopic dermatitis - moderate severe | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
Emollients | Dry and pruritic skin conditions | n/a | Patient information | Hertfordshire and West Essex ICB |
Etanercept | Psoriasis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Fluorouracil 0.5% / Salicylic acid 10% cutaneous solution | Actinic keratosis | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
Fungal Nail Management | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
Glycopyrronium bromide | Hyperhidrosis | Double Red | Decision document | Hertfordshire and West Essex ICB |
Guselkumab | Psoriasis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Hair Transplantation | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
Hyperhidrosis | Hyperhidrosis - self help | n/a | Patient information | Hertfordshire and West Essex ICB |
Hyperhidrosis | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
Hyperhidrosis Management | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
Imiquimod 3.75% cream | Actinic keratosis | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
Imiquimod 5% cream | Actinic keratosis | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
Infliximab IV | Psoriasis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Isotretinoin | Acne | Red | n/a | Hertfordshire and West Essex ICB |
Ivermectin 10mg/ml cream | Papulopustular rosacea | Green | Decision document | Hertfordshire and West Essex ICB |
Ixekizumab | Psoriasis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Lebrikizumab | Atopic dermatitis - moderate to severe | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
Mepacrine (unlicensed medicine) | Subacute cutaneous and Discoid lupus erythematosus | Red | n/a | Hertfordshire and West Essex ICB |
Methoxsalen | Cancer, psoriasis | Red | n/a | Hertfordshire and West Essex ICB |
Minocycline | Acne | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
Minocycline Patient information leaflet | Acne | n/a | Patient information | Hertfordshire and West Essex ICB |
Omalizumab | Urticaria - severe chronic | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
Pigmanorm | Melasma | Double Red | Decision document | Hertfordshire and West Essex ICB |
Plastics Referral Pathway (including scar revision) | n/a | Patient information | Hertfordshire and West Essex ICB | |
Prednisolone | All indications - soluble tablet | n/a | Patient information | Hertfordshire and West Essex ICB |
Prednisolone enteric coated | All indications | Double Red | n/a | Hertfordshire and West Essex ICB |
Promethazine | All indications | n/a | Position statement | Hertfordshire and West Essex ICB |
Psoriasis | Psoriasis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Psoriasis | Psoriasis - severe localised | Red | Decision document | Hertfordshire and West Essex ICB |
Removal Of Abnormally Placed Hair and Hirsutism | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
Rhinophyma Surgical Treatment | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
Risankizumab | Psoriasis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Ritlecitinib | Alopecia areata - severe | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
Scar Revision | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
Scar Revision Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
Secukinumab | Psoriasis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Silk Garments | Eczema dermatitis | n/a | Patient information | Hertfordshire and West Essex ICB |
Silk garments | Eczema dermatitis | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
Skin Cancer Suspected - Pigmented Lesion/ Melanoma/ SCC/ BCC | n/a | Patient information | Hertfordshire and West Essex ICB | |
Sunscreens | Protection against UV radiation (ACBS) | Green | Decision document | Hertfordshire and West Essex ICB |
Sunscreens | Protection against UV radiation (ACBS) | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
Surgical Removal of Benign Skin Lesions | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
Surgical Removal of Benign Skin Lesions Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
Tattoo Removal | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
Tildrakizumab | Psoriasis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Tirbanibulin | Actinic keratosis | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
Tralokinumab | Atopic dermatitis - moderate severe | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
Upadacitinib | Atopic dermatitis - moderate severe | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
Ustekinumab | Psoriasis - moderate severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |